PRESS/EVENTS

04.07.2019 15:59

Managing Director

Dr. Georg Lentzen has been appointed as Managing Director of b.value AG as of 01.07.2019. He brings in-depth expertise and knowledge of biotechnological processes, and their commercialisation in young companies, to accelerate the positive development of b.value AG.

Dr Lentzen comes with over 20 years of experience in various leadership roles in biotech companies in the United Kingdom, Germany and The Netherlands. Prior to joining b.value AG, he was Director R&D at the Dutch biotech company Isobionics B.V. where he coordinated the development of a biotech platform for terpene-based flavour and fragrance products. Earlier in his career, he was responsible for R&D at bitop AG (Germany) and led a team in drug discovery at Vernalis plc (UK). Dr. Lentzen received a PhD in biochemistry from the University Witten/Herdecke.

At the same time, Dr. Thomas Schwarz is leaving the management team of the b.value AG. He will continue to support the company as shareholder and ideas provider.

Further information: b.value management team

 

Go back

©markusspiske, pixabay.com (newspaper im header)  -  ©TeroVesalainen, pixabay.com (light bulb/board)  -  ©moerschy, pixabay.com (money)  -  ©brittaneu, pixabay.com (glasses)  -  ©mohamed_hassan, pixabay.com (panel founding) - ©rawpixel, pixabay.com (shake hands) -  ©iMod-design, pixabay.com (calculator) -

Copyright 2019 b.value AG
This site uses necessary cookies to help make this website usable by providing basic features such as site navigation and access to secure areas of the site and technical protection against misuse. More information about privacy
ACCEPT!